Delivery Order SPE2DE23D0008-SPE2D625F0ZZR
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,425.00 for Natrelle Inspira SCM 560CC breast implants by the Defense Logistics Agency Medical Supply Chain, a Defense agency division. The award, issued on August 14, 2025, represents a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The contract was awarded without set-aside designation, reflecting Allergan's status as a...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $3,021 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SCF 415CC breast implants. The contract, which carries no set-aside designation, reflects Allergan's status as a sole-source provider of specialized reconstructive and aesthetic surgical devices to the federal government. The award is structured as a fixed-price contract with economic price adjustment, with performance...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $1,200 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SSF 325CC breast implants. This delivery order, awarded on July 24, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements. The contract does not utilize a set-aside designation, reflecting Allergan's position...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $2,814 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to supply Natrelle Inspira SSM 405cc breast implants. Performance will occur at Allergan's facility in Irvine, California, with no set-aside designation applied. As a sole-source provider of proprietary breast implant products, Allergan will deliver the devices to support reconstructive surgeries at military treatment facilities. This award is...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for Natrelle TE Smooth 133S breast implants. The contract, awarded on August 19, 2025, with an ultimate completion date of August 21, 2025, represents a child order under one of Allergan's two significant Indefinite Delivery Vehicles established with DLA Troop Support Medical. This $13.5 million IDV, awarded on December 8, 2022, supports...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a $1,425.00 fixed-price delivery order to Allergan USA Inc., a subsidiary of AbbVie Inc., for the supply of 405cc Natrelle Inspira breast implants. This order is part of a larger $13.5 million Indefinite Delivery Vehicle (IDV) contract that Allergan holds with the Defense Logistics Agency Troop Support Medical for the provision of breast implants, surgical instruments, and related medical items. Allergan also...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F0ZZRDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a fixed-price delivery order valued at $3,021.00 for Natrelle Inspira SCLP 300cc breast implants from the Defense Logistics Agency's Medical Supply Chain division. This delivery order, which carries no set-aside designation, was awarded on August 14, 2025, with an ultimate completion date of August 18, 2025, and will be performed at Allergan's facility in Irvine, California. The award reflects Allergan's status as a sole-source provider of specialized breast implants to federal healthcare systems. This delivery order is issued under Allergan's broader Indefinite Delivery Vehicle contracts with DLA Troop Support Medical, which were established on December 8, 2022, and total $13.5 million in potential value for Natrelle breast implants and surgical devices. The pricing structure includes economic price adjustment provisions to account for cost fluctuations. The medical devices supplied through this contract support reconstructive and aesthetic surgical procedures at military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers, serving military members, veterans, and Native American populations across the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/14/25 |